Zhiqiang Shu is a biotech investor. He currently serves as a Biotech Investor at Moore Capital Management. His career includes roles as a Biotech Investor at Alliancebernstein and Laurion Capital Management Lp.

Earlier in his career, Shu worked in Biotech Equity Research at Bmo Capital Markets and in Berenberg Capital Markets. He also held a position as a Strategy Consultant at Putnam.